ArticleMedicina (Kaunas, Lithuania)2026

Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan.

Arwa Al Anber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.